|
Cours en clôture
Shenzhen S.E.
30/09/2026
|
Varia. 5j. | Varia. 1 janv. | ||
| 5,320 CNY | +2,90% |
|
+4,72% | -16,09% |
| 24/09 | Shanghai RAAS Blood Products va acquérir l’unité de Boehringer Ingelheim | MT |
| 21/09 | RAAS Blood Products obtient un certificat d'enregistrement pour le fibrinogène humain | MT |
Principaux concurrents
Ajouter à une liste 0 sélectionné | Varia. | Varia. 5j. | Variation 1 mois | Variation 3 mois | Varia. 1 janv. | Varia. 1an | Varia. 3ans | Varia. 5ans | Varia. 10ans | Capi.($) | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +2,90% | +4,72% | +8,13% | +15,40% | -16,09% | -20,48% | -23,56% | -21,99% | -76,09% | 5,23 Md | |
| +0,02% | -3,52% | -0,54% | -5,83% | +6,37% | +36,11% | +111,11% | +395,01% | +1 298,31% | 1 019 Md | |
| -1,21% | -6,99% | -8,10% | -3,84% | +22,22% | +34,08% | +60,96% | +58,50% | +112,23% | 610 Md | |
| +1,12% | -0,20% | +3,63% | +1,80% | +16,31% | +13,62% | +80,24% | +142,68% | +319,25% | 470 Md | |
| -3,30% | -6,15% | -7,18% | +7,70% | +32,57% | +56,45% | +34,69% | +71,00% | +122,20% | 344 Md | |
| +1,66% | +1,52% | +0,28% | +6,87% | +8,04% | +22,95% | +42,93% | +1,46% | +48,18% | 336 Md | |
| +1,49% | -2,33% | -5,87% | -5,60% | +7,76% | +11,63% | +33,63% | +56,26% | +53,68% | 266 Md | |
| +2,57% | -3,14% | -0,03% | -14,62% | -12,70% | -5,41% | +10,02% | +37,14% | +139,51% | 241 Md | |
| -0,01% | -3,62% | -7,83% | +7,71% | +23,12% | +35,28% | +52,02% | +90,21% | +140,96% | 218 Md | |
| -0,08% | -4,98% | -4,22% | +10,18% | +17,83% | +28,34% | +93,61% | +114,58% | +86,45% | 179 Md | |
| +0,85% | -0,99% | -16,66% | -22,41% | -23,40% | -35,55% | -61,39% | -19,78% | +82,19% | 164 Md | |
| -1,40% | -4,56% | -3,66% | +12,71% | +10,08% | +0,15% | -18,11% | -35,23% | -19,14% | 156 Md | |
| -0,24% | -4,58% | -7,80% | -4,65% | +11,06% | +24,85% | +41,78% | +184,45% | +474,44% | 128 Md | |
| -3,83% | -7,94% | -11,99% | +1,17% | +9,03% | +29,39% | +4,24% | -0,57% | +7,34% | 120 Md | |
| +1,46% | +6,91% | +0,82% | +16,43% | +11,60% | +24,03% | +105,35% | +361,84% | +452,57% | 107 Md | |
| +2,10% | -0,06% | -5,63% | -4,13% | -13,65% | -16,73% | -30,11% | -13,89% | +3,85% | 93,99 Md | |
| +1,18% | -4,22% | -3,25% | -10,35% | -2,57% | +10,01% | +18,56% | +3,03% | -15,37% | 93,19 Md | |
| +6,95% | +3,01% | +39,62% | +154,78% | +589,08% | +613,27% | +97,35% | -38,81% | - | 81,13 Md | |
| -1,19% | -3,43% | -12,23% | +11,04% | -5,88% | +21,08% | -12,59% | +31,87% | +85,04% | 72,54 Md | |
| +4,06% | +2,95% | +4,70% | -0,95% | +15,38% | +17,68% | -9,62% | -24,26% | +46,75% | 66,31 Md | |
| Moyenne | +0,68% | -2,34% | -1,89% | +8,67% | +35,31% | +45,04% | +31,55% | +69,67% | +176,97% | 238,48 Md | |
| Moyenne pondérée par Capi. | +0,67% | -3,23% | -2,93% | +1,60% | +20,36% | +33,72% | +55,19% | +135,02% | +388,53% |
- Bourse
- Actions
- Action 002252
- Secteur Shanghai RAAS Blood Products Co., Ltd.
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
